13F
← All fund report cards

BAMCO INC /NY/

13F equity value
$33.1B
Positions
326
Top 10 concentration
41.5%
Quarters / total new picks
32 / 447
13F equity value over time
$0M$24B$47B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +4.6% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 56.2% of quarters (excess t = 0.29, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+0.5%
t-stat
0.29
Quarterly win rate
56%
Annualized excess
+6.3%
$1 → follow vs universe
$3.27 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.02120180630: follow 0.96820180930: follow 1.04520181231: follow 1.07620190331: follow 1.10020190630: follow 1.13420190930: follow 1.19020191231: follow 1.03220200331: follow 1.17120200630: follow 1.46020200930: follow 2.15220201231: follow 2.16920210331: follow 2.54920210630: follow 2.87720210930: follow 2.45320211231: follow 1.79520220331: follow 1.82820220630: follow 1.73720220930: follow 1.76920221231: follow 1.75620230331: follow 1.98420230630: follow 2.12720230930: follow 2.61620231231: follow 2.90220240331: follow 3.31720240630: follow 3.73720240930: follow 3.76120241231: follow 3.33220250331: follow 3.27520250630: follow 3.29620250930: follow 3.41520251231: follow 3.273 0.84 2.45 4.06 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 326 · 2026 Q1

Ticker Value Weight QoQ
TSLA $4.4B
13.4%
HOLD
ACGL $1.6B
4.8%
TRIM
MSCI $1.5B
4.4%
TRIM
GWRE $987M
3.0%
ADD
IT $937M
2.8%
ADD
IDXX $918M
2.8%
TRIM
H $912M
2.8%
ADD
FIGS $886M
2.7%
HOLD
FDS $815M
2.5%
ADD
CHH $796M
2.4%
ADD
RRR $716M
2.2%
ADD
SCHW $701M
2.1%
ADD
KNSL $693M
2.1%
ADD
CSGP $658M
2.0%
TRIM
MTN $647M
1.9%
ADD
SPOT $640M
1.9%
ADD
SHOP $560M
1.7%
ADD
NVDA $509M
1.5%
TRIM
VRSK $477M
1.4%
ADD
BIRK $336M
1.0%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.